Fora Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $585,263 - $890,048	-13,504 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $314,643 - $804,433	13,504 New	13,504 $740,000
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $61,951 - $86,398	-3,022 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $40,253 - $68,327	3,022 New	3,022 $63 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.